Who are AGC Biologics's investors?

AGC Biologics's investors include Boulder Ventures, European Equity Partners.

Where is AGC Biologics headquartered?

AGC Biologics is headquartered in Seattle, US.

AGC Biologics

Seattle, US · 2 known investors

Find your way into AGC Biologics

Each arrow is one introduction. Sign up to fill in the first one.

1,492 people can intro you to Alberto

Ask David Yeow to introduce you to Alberto Santagostino

You →David · together at LANXESS AG →Alberto

34 people can intro you to Christoph

Ask Jamie Chen to introduce you to Christoph Winterhalter

You →Jamie · together at Wacker Chemie AG →Christoph

Your email: who you already know at AGC Biologics, and who your contacts know
2nd- and 3rd-degree connections: people you know who worked, studied or invested with the AGC Biologics team
Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

AGC Biologics is a contract development and manufacturing organization (CDMO) providing biopharmaceutical manufacturing services including cell therapy, mammalian, and mRNA-LNP production. The company operates multiple sites globally and is expanding its Japan capabilities with a new GMP-ready facility in Yokohama launching in 2027.

Advanced Manufacturing Biotech Enterprise Software Healthtech Medical Devices

Founders & leadership

Alberto Santagostino Chief Executive Officer and PresidentAlberto Santagostino is Chief Executive Officer and President of AGC Biologics, a contract development and manufacturing organization providing biopharmaceutical manufacturing services.

Kasper MøllerChief Technical Officer and Executive Vice President, Europe & Japan RegionsChief Technical Officer and Executive Vice President, Europe & Japan Regions at Agcbio

Christoph Winterhalter Chief Business OfficerChristoph Winterhalter is Chief Business Officer of AGC Biologics, a contract development and manufacturing organization for biopharmaceuticals. He has more than 20 years of experience in life sciences across Europe and the US, including general management and P&L responsibility for biologics CDMO operations, global sales leadership, and key account management with multinational pharmaceutical companies.

Yuichiro TashiroExecutive Vice President, Corporate FunctionsExecutive Vice President, Corporate Functions at Agcbio

Carrie MygattExecutive Vice President, Finance

Luca AlbericiExecutive Vice President, Global Cell & Gene Technologies and General Manager, Milan FacilityExecutive Vice President, Global Cell & Gene Technologies and General Manager, Milan Facility at Agcbio

Kohei YokoyamaExecutive Vice President, Region Japan Facilitator

Motoi AokiHead of Global Quality

Investors · 2

Boulder Ventureslisted by Boulder VenturesBoulder · $1M – $4M

European Equity Partnerslisted by European Equity PartnersGuernsey · $540K – $10.8M

Frequently asked questions

What does AGC Biologics do?: AGC Biologics is a contract development and manufacturing organization (CDMO) providing biopharmaceutical manufacturing services including cell therapy, mammalian, and mRNA-LNP production. The company operates multiple sites globally and is expanding its Japan capabilities with a new GMP-ready facility in Yokohama launching in 2027.
Who are AGC Biologics's investors?: AGC Biologics's investors include Boulder Ventures, European Equity Partners.
Where is AGC Biologics headquartered?: AGC Biologics is headquartered in Seattle, US.